X4 Pharmaceuticals (XFOR) Tops Q1 EPS by 5c

X4 Pharmaceuticals (NASDAQ: XFOR) reported Q1 EPS of ($0.16), $0.05 better than the analyst estimate of ($0.21).

For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.

You May Also Be Interested In

• JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
• Paychex beats fourth quarter EPS estimates, stock slides
• FedEx (FDX) PT Lowered to $397 at Bernstein SocGen Group